scholarly journals Effect of Dance Movement Therapy on Depression and Anxiety for Persons with Dementia: A Systematic Review

2021 ◽  
Vol 5 (Supplement_1) ◽  
pp. 643-643
Author(s):  
Ying Wang ◽  
Mandong Liu ◽  
Jing Wu ◽  
Zhixiao Dong ◽  
Huan Cui ◽  
...  

Abstract Dance movement therapy(DMT)is a physical and psychological intervention, but there was no meta-analysis of RCTs in the systematic review of DMT for dementia, and the results of RCTs were inconsistent. The study aimed to assess the effectiveness of dance movement therapy on depression and anxiety of persons with dementia in comparison to no treatment, standard care. Six electronic databases (Cochrane, PsycINFO, Web of Science, PubMed, EBSCO, CNKI) were searched through January 2021. Randomized controlled trials (RCTs) in Chinese and English language were considered, including: (1) population is women and men of all age with dementia and MCI; (2) intervention is dance movement intervention; (3) comparison is no treatment or standard care; (4) outcome is depression or anxiety. The four review authors independently reviewed studies on an abstract/title level and again after reading the full paper, and we independently evaluated methodological quality. Six randomized controlled trials were identified on depression and anxiety symptoms in persons with dementia. The target sample size was 29-842 older adults. Meta-analysis showed there were significant differences in favor of dance in depression (SMD = 1.17, 95% CI: 0.39 to 1.95, P = 0.003), but not in outcomes of anxiety. Trials of high methodological quality, large sample sizes, and clarity in the way the intervention is put together and delivered are needed to assess whether dance movement therapy is an effective intervention on depression and anxiety for persons with dementia.

Author(s):  
Regina El Dib ◽  
Aravind Gandhi Periyasamy ◽  
Jessica Lima de Barros ◽  
Carolina Gonzales França ◽  
Fernanda Labiapari Senefonte ◽  
...  

2020 ◽  
Author(s):  
Hon Lon Tam ◽  
Eliza Mi Ling Wong ◽  
Kin Cheung ◽  
Siu Fung Chung

BACKGROUND Controlling blood pressure (BP) is an international health concern, and high BP is a major contributor to cardiovascular disease mortality. Evidence has shown that educational interventions directed at patients potentially improve BP control and adherence to medications and lifestyle modifications. In addition, a text messaging intervention has a potential effect on BP control; however, the dosage of a text messaging intervention has not been determined in previous reviews, resulting in difficult application in practice. OBJECTIVE This review aimed to identify the effectiveness of a text messaging intervention on hypertension management with a specific focus on the dosage of text messaging and the type of additional interventions with text messaging. METHODS A systematic review was conducted and reported on in accordance with PRISMA guideline. Participants were aged 18 years and older and diagnosed with primary hypertension. The included studies used text messaging as a component of the intervention. We searched for randomized controlled trials published until June 30, 2020, from the following health-related electronic databases: Embase, Medline, CINAHL Complete, PsycINFO, and Scopus. Data were extracted for qualitative synthesis and meta-analysis. The Physiotherapy Evidence Database Scale was used to assess the methodological quality of each study, and the quality of the included studies was assessed independently by two authors. RESULTS Twelve studies met the inclusion criteria. The overall methodological quality was fair (mean score 5.75). The frequency of text message delivery varied from daily to biweekly. Health education was identified in 4 studies as an additional intervention with text messaging. The overall results showed that the text messaging intervention significantly reduced systolic BP (SBP) but not diastolic BP (DBP). There was no significant difference in BP reduction between studies that lasted 6 months or less and those that lasted more than 7 months. Seven studies that lasted 6 months or less involving 1428 patients with hypertension were pooled for further meta-analysis. Text messages delivered at a lower frequency (once per week or less) had a small effect on SBP reduction (effect size 0.35, <i>P</i>&lt;.01) and DBP reduction (effect size 0.28, <i>P</i>=.01). In addition, the use of a text messaging intervention halved the odds of uncontrolled BP among patients with hypertension in 6 months (odds ratio 0.46, <i>P</i>=.02). CONCLUSIONS This review found that a text messaging intervention was effective in BP control. One-way text messaging delivered in a weekly manner was suggested to be effective and required fewer resources. Future studies should use different forms of text message and be integrated into other interventions to improve adherence behaviors and BP control among patients with hypertension.


Nutrients ◽  
2020 ◽  
Vol 12 (9) ◽  
pp. 2795
Author(s):  
Munji Choi ◽  
Seongmin Park ◽  
Myoungsook Lee

A systematic review and meta-analysis of randomized controlled trials (RCTs) was carried out to assess L-carnitine supplements’ influence on the biomarkers of metabolic syndrome (MetSyn). PubMed, EMBASE, Cochrane library, and CINAHL were used to collect RCT studies published prior to February 2020. RCT studies were included if they had at least one of the following biomarker outcome measurements: waist circumference (WC), blood pressure (BP), fasting blood sugar (FBS), triglyceride (TG), or high density lipoprotein-cholesterol (HDLc). Nine of twenty studies with adequate methodological quality were included in this meta-analysis. The dose of L-carnitine supplementation administered varied between 0.75 and 3 g/day for durations of 8–24 weeks. L-carnitine supplementation significantly reduced WC and systolic BP (SBP), with no significant effects on FBS, TG, and HDLc. We found that L-carnitine supplementation at a dose of more than 1 g/d significantly reduced FBS and TG and increased HDLc. In conclusion, L-carnitine supplementation is correlated with a significant reduction of WC and BP. A dose of 1–3 g/d could improve the biomarkers of MetSyn by reducing FBS and TG and increasing HDLc.


2021 ◽  
Author(s):  
Hugh Cameron McCall ◽  
Heather D Hadjistavropoulos ◽  
Christopher Richard Francis Sundström

BACKGROUND Internet-delivered cognitive behavioural therapy (ICBT) is an effective treatment that can overcome barriers to care. Various research groups have suggested that unguided ICBT (i.e., ICBT without therapist support) and other eHealth interventions can be designed in ways that enhance user engagement and thus outcomes. The persuasive systems design framework captures most design recommendations for eHealth interventions, but there is little empirical support that persuasive design is related to clinical outcomes in unguided ICBT. OBJECTIVE One objective of this study was to provide an updated meta-analysis of randomized controlled trials of unguided ICBT for depression and anxiety. Another objective was to describe the use of persuasive design in such interventions. A third objective was to employ meta-regression to explore whether a greater number of persuasive design elements predicts efficacy in unguided ICBT for depression and anxiety. METHODS We conducted a systematic review of five databases to find randomized controlled trials of unguided ICBT for depression and anxiety. We conducted separate random-effects meta-analyses and separate meta-regressions for depression and anxiety interventions. Each meta-regression included two steps. The first step included, as a predictor, whether each intervention was transdiagnostic. For the meta-regression of ICBT for depression, the first step also included the type of control condition. The number of persuasive design principles identified for each intervention was added as a predictor in the second step to reveal the additional variance in effect sizes explained by persuasive design. RESULTS We identified 4,471 articles in our search, 46 of which were eligible for inclusion in our analyses. Our meta-analyses showed effect sizes (Hedges’ g) ranging from 0.22 to 0.31 for depression interventions, depending on the measures taken to account for bias in the results. We found a mean effect size of 0.45 for anxiety interventions, with no evidence that results were inflated by bias. Included interventions were identified as employing an average of 4.88 persuasive design principles. The meta-regressions showed that a greater number of persuasive design principles predicted greater efficacy in ICBT for depression (R2 change=.27, B=0.04, P=.02) but not anxiety (R2 change=.05, B=0.03, P=.17). CONCLUSIONS These findings provide preliminary support for the proposition that more persuasively designed ICBT interventions are more efficacious, at least in the treatment of depression. Further research is needed to clarify the role of persuasive design in ICBT. CLINICALTRIAL PROSPERO (https://www.crd.york.ac.uk/prospero/) CRD42020153466


2016 ◽  
Vol 2016 ◽  
pp. 1-8 ◽  
Author(s):  
Chao-qin Gou ◽  
Jing Gao ◽  
Chen-xi Wu ◽  
Ding-xi Bai ◽  
Hong-yuan Mou ◽  
...  

Primary dysmenorrhea (PD) is one of the most common diseases in gynecology at present. Some clinical trials have reported the effects of moxibustion and confirmed temporal factors are the important elements influencing the efficacy of moxibustion. However, no systematic review has yet been conducted. In this study, we assessed the effects of moxibustion in patients with PD enrolled in randomized controlled trials (RCTs) and the difference among different intervention times to start moxibustion. We extracted data for studies searched from 10 electronic databases and evaluated the methodological quality of the included studies. We discussed three outcomes: effective rate, pain remission, and the level of PGF2αin serum. Current clinical researches showed that, compared with nonmoxibustion treatments for PD, moxibustion leads to higher effective rate and lower level of PGF2αin serum. However, there was no difference in using moxibustion to treat PD at different intervention times. Based on the theory of Chinese medicine and the results of this study, choosing 5 ± 2 days before menstruation to start moxibustion can achieve good efficacy for PD patients. However, more high-quality RCTs are needed to confirm the conclusions.


2019 ◽  
Vol 42 (4) ◽  
pp. 434-440 ◽  
Author(s):  
Francesco Bortolotti ◽  
Livia Solidoro ◽  
Maria Lavinia Bartolucci ◽  
Serena Incerti Parenti ◽  
Corrado Paganelli ◽  
...  

Summary Background Surgically assisted rapid maxillary expansion (SARME) is a surgical technique developed to correct transverse discrepancies in skeletally mature patients. However, there is limited evidence concerning the immediate skeletal and dental changes obtained only due to SARME. Objective The aim of the present systematic review is to investigate the immediate skeletal and dental effects of SARME in adult patients with transverse maxillary hypoplasia. Search Methods An electronic search of the literature in MEDLINE, The Cochrane Library, Lilacs and Scopus databases was performed. Selection Criteria Only randomized controlled trials (RCTs) studies investigating the skeletal and dental effects of SARME procedures in adult patients were included. Data Collection and Analysis The included studies received a methodological quality scoring according to the revised Cochrane risk-of-bias tool for randomized trials. The quality of evidence was assessed by means of the Grading Recommendation Assessment, Development and Evaluation (GRADE) system. For each included study and for each analysed parameter, the difference in means and 95 per cent confidence interval was calculated between baseline and immediate post-expansion. A meta-analysis of original outcome data, if possible, was conducted. Results Nine articles were selected. The methodological quality ratings indicated that one study was at low risk of bias, seven presented some concerns and only one was at high risk of bias. In all the included studies, the SARME procedure resulted in a significant expansion of the maxillary transverse dimension. The meta-analysis compared skeletal and dental inter-molar width before and after treatment: the mean difference was of 3.3 mm (2.8–3.9) and 7.0 mm (6.1–7.8), respectively (P-value less than 0.001). The quality of evidence was low-moderate. Conclusions SARME is effective in obtaining a significant expansion of the maxillary transverse dimension. However, the immediate SARME effect is mainly a molar expansion rather than a pure bone transverse widening of the maxilla. Registration The review protocol was registered at PROSPERO database with the registration number CRD42018117967.


2018 ◽  
Author(s):  
David R Vago ◽  
Resh Gupta ◽  
Sara Lazar

One potential pathway by which mindfulness-based meditation improves health outcomes is through changes in cognitive functioning. A systematic review of randomized controlled trials of mindfulness-based interventions (MBIs) was conducted with a focus on assessing the state of the evidence for effects on cognitive processes and associated assays. Here, we comment on confounding issues surrounding the reporting of these and related findings, including 1) criteria that appropriately define an MBI; 2) limitations of assays used to measure cognition; and 3) methodological quality of MBI trials and reporting of findings. Because these issues contribute to potentially distorted interpretations of existing data, we offer constructive means for interpretation and recommendations for moving the field of mindfulness research forward regarding the effects on cognition.


Sign in / Sign up

Export Citation Format

Share Document